About one in four cancer drugs however are not going to be in the ambit of price control as they are patented, single source molecules.
The dust has still not settled over the price control of cancer drugs that came into force earlier this week but for consumers the big question is how to check whether they have been charged the correct and revised price for the medicines they are using. The answer may lie in the Pharma Sahi Price app.
In a post on X, the Press Information Bureau has given the ways for both verification and redress. “MRPs of anti-cancer medicines reduced by up to 96.45%➠ Not a discount. Not a scheme. The revised MRP is printed on the pack and applies in every pharmacy and hospital, from today ➠ Check the price on the Pharma Sahi Daam app➠ If charged more, complain to NPPA via the Pharma Sahi Daam app/ portal or call 1800-111-255″.
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, capped trade margins on MRP of 137 anti-cancer drugs, based on the recommendations of Expert Committee constituted by the Directorate General of Health Services (DGHS) under Ministry of Health & Family Welfare on 17th October, 2026. Following the order, 1364 formulations now carry lower prices across the country.
Every retailer, dealer, hospital and institution is required to prominently display Revised MRP list of anti-cancer medicines on their websites and in their premises
The Expert Committee comprised leading oncologists, medical specialists, experts from hospitals across the country, and Government officers. About one in four cancer drugs however are not going to be in the ambit of price control as they are patented, single source molecules.
TMR of non-scheduled anti-cancer medicines is an important step taken by the Government in its continued efforts to improve affordability and accessibility of essential anti-cancer medicines for cancer care.
The Octoiber notification will remain in force until further orders However, manufacturers can avail annual price increase in accordance with the provisions of Paragraph 20(1) of the Drugs (Prices Control) Order, 2013, subject to continued compliance with the maximum permissible trade margin of 30%
Every retailer, dealer, hospital and institution is required to prominently display Revised MRP list of anti-cancer medicines on their websites and in their premises. As per the NPPA notification, State Drug Controllers will monitor compliance by manufacturers, dealers, Hospitals and Medical Institutions.
